AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6463068
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg econazole
Trial: 31905348
Drug: GINA guidelines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GINA guidelines + FENO modification for ICS titration (group 2)
Trial: 28546012
Drug: Clonidine 1
RxNorm normalized name: apraclonidine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 mcg.kg−1
Trial: 28546012
Drug: Dexmedetomidine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.5 mcg.kg−1
Trial: 24530273
Drug: Agomelatine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine 10 mg/day (n=133)
Trial: 24530273
Drug: Agomelatine 25
RxNorm normalized name: Agomelatine 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine 25 mg/day (n=138)
Trial: 24530273
Drug: Agomelatine 25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine 25-50 mg/day (n=137)
Trial: 26708320
Drug: Agomelatine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine 10 mg/day
Trial: 24530273
Drug: Agomelatine 25
RxNorm normalized name: Agomelatine 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine 25 mg and 25-50 mg/day
Trial: 24530273
Drug: Agomelatine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine (all doses)
Trial: 15002600
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment including high caloric intake, Calcium and Vitamin D supplementation
Trial: 21669954
Drug: dexamethasone 0.1
RxNorm normalized name: dexamethasone 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexamethasone 0.1 mg kg(‐1)
Trial: 21669954
Drug: dexamethasone 0.05
RxNorm normalized name: dexamethasone 0.05 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexamethasone 0.05 mg kg(‐1)
Trial: 16906286
Drug: Tomato paste
RxNorm normalized name: Tomato
DrugBank: Tomato (DB10573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato paste (50 g daily for 10 weeks)
Trial: 19798465
Drug: Enteral nutrition
RxNorm normalized name: ENTERAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral nutrition (EN) - elemental diet infusion during night-time and a low fat diet during daytime; 32 patients in the EN group.
Trial: 19798465
Drug: Non-nutritional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-nutritional therapy (non-EN) - no nutritional therapy or food restriction; 24 patients in the non-EN group.
Trial: 17622759
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg sarpogrelate, orally, three times daily for 7 days
Trial: 17622759
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sarpogrelate, orally, three times daily for 7 days
Trial: 17622759
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sarpogrelate, orally, three times daily for 7 days
Trial: 12177804
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg (n=12)
Trial: 12177804
Drug: Anastrozole 10
RxNorm normalized name: anastrozole 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 10 mg (n=11)
Trial: 12177804
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg or 10 mg)
Trial: 10205205
Drug: Prucalopride 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 0.5 mg
Trial: 25534573
Drug: Prucalopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 2 mg
Trial: 19035970
Drug: Prucalopride 4
RxNorm normalized name: PRUCALOPRIDE
DrugBank: Prucalopride (DB06480)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Prucalopride 4 mg
Trial: 10205205
Drug: Prucalopride (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride (0.5, 2, and 4 mg doses)
Trial: 27804205
Drug: Two mini
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two mini dental implants with Equator attachments
Trial: 27804205
Drug: Four mini
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four mini dental implants with Equator attachments
Trial: 27804205
Drug: Two conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two conventional dental implants with ball attachments
Trial: 29381374
Drug: Hyperglycemia (130
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperglycemia (130 mg/dl)
Trial: 29381374
Drug: Normoglycemia (95
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normoglycemia (95 mg/dl)
Trial: 29381374
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and leptin levels
Trial: 28277490
Drug: Erythropoietin (EPO)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (EPO) 500 U kg‐1 per dose in 2 ml saline intravenously, given on alternate days for a total of five doses
Trial: 28277490
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (placebo group), 2 ml given similarly for a total of five doses
Trial: 26590242
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose motivational interviewing (10 calls)
Trial: 24899321
Drug: 2ml (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2ml (10 mg) hyperbaric bupivacaine 0.5% plus 25 mg preservative free ketamine
Trial: 8864680
Drug: Omeprazole 40mg
RxNorm normalized name: OMEPRAZOLE 40MG CAP,SA
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 40mg once daily for 5 days
Trial: 8864680
Drug: Omeprazole 80mg
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 80mg once daily for 5 days
Trial: 31574029
Drug: Topical Minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Minoxidil
Trial: 26705327
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic fields (PEMF) therapy for 12 hours daily for 1 month
Trial: 22658168
Drug: Nerve stimulation
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve stimulation guided obturator nerve block with 15 mL of lidocaine HCl 2%
Trial: 22658168
Drug: Nerve stimulation
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve stimulation guided obturator nerve block with 20 mL of saline
Trial: 29246151
Drug: Lipid-lowering therapy
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-lowering therapy
Trial: 1519391
Drug: Amoxicillin/Clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/Clavulanic acid (group B)
Trial: 10190769
Drug: Ibuprofen (2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (2400 mg x d(‐1))
Trial: 18092435
Drug: Intraumbilical vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraumbilical vein oxytocin (10 units diluted with 10 ml of normal saline)
Trial: 11443192
Drug: Pulsatile iv
RxNorm normalized name: PULSATILLA PRATENSIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsatile iv GnRH administration (0.1 microg/kg every 90 min)
Trial: 8033141
Drug: M‐CSF at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M‐CSF at 100 micrograms/kg/day and gamma‐IFN at 0.1 mg/m2/day
Trial: 8033141
Drug: M‐CSF therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M‐CSF therapy alone at the same dose
Trial: 8033141
Drug: M‐CSF and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M‐CSF and gamma‐IFN therapy
Trial: 29933355
Drug: Caffeine (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (800 mg)
Trial: 27610609
Drug: Amoxicillin-clavulanate 875
RxNorm normalized name: amoxicillin-clavulanate 875 mg-125 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate 875 mg/125 mg twice daily (BID) for 14 days
Trial: 16573163
Drug: Integrin and
RxNorm normalized name: DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN 11
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrin and FAK antibody blocking
Trial: 10743865
Drug: 25% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% metronidazole gel
Trial: 1598954
Drug: norfloxacin ophthalmic
RxNorm normalized name: norfloxacin ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: norfloxacin ophthalmic solution 0.3%
Trial: 24191305
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (ramipril and telmisartan)
Trial: 24191305
Drug: Monotherapy (ramipril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (ramipril or telmisartan)
Trial: 22301410
Drug: IL-2 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-2 therapy (6 million units, twice daily for 5 days at weeks 0, 8, and 16)
Trial: 20618582
Drug: Medication and
RxNorm normalized name: CVS Health Medication and Topical Refill Pouch KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication and medication referral as a treatment option
Trial: 2566293
Drug: Thymomodulin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymomodulin (80 mg daily orally)
Trial: 20825791
Drug: Secobarbital 100
RxNorm normalized name: secobarbital 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secobarbital 100 mg
Trial: 30427741
Drug: V180 formulations
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: V180 formulations with ISCOMATRIX™ adjuvant
Trial: 30427741
Drug: Aluminum-adjuvanted formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum-adjuvanted formulations
Trial: 30427741
Drug: Unadjuvanted formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unadjuvanted formulations
Trial: 30427741
Drug: All 9
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All 9 V180 formulations
Trial: 30427741
Drug: Formulations with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulations with ISCOMATRIX™ adjuvant
Trial: 29369527
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of DEX and DICL
Trial: 27055444
Drug: Long-term interdisciplinary
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term interdisciplinary treatment (LG) - 10 sessions of cognitive behavioral therapy (CBT) and exercise training for 10 weeks.
Trial: 27055444
Drug: Short-term interdisciplinary
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term interdisciplinary treatment (SG) - 2 full days of educational, exercise, and CBT programs.
Trial: 24739759
Drug: CDX-1401 vaccine
RxNorm normalized name: CDX
DrugBank: Cefadroxil (DB01140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CDX-1401 vaccine with TLR agonists (resiquimod and Hiltonol)
Trial: 24739759
Drug: CDX-1401 vaccine
RxNorm normalized name: CDX
DrugBank: Cefadroxil (DB01140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CDX-1401 vaccine
Trial: 24739759
Drug: CDX-1401 vaccine
RxNorm normalized name: CDX
DrugBank: Cefadroxil (DB01140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CDX-1401 vaccine followed by immune-checkpoint inhibitors
Trial: 19065903
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg per day + NXT 9 tablets per day
Trial: 19065903
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg per day
Trial: 16317530
Drug: Percutaneous dorsal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous dorsal instrumentation (PER-G)
Trial: 16317530
Drug: Open procedure
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open procedure (OP-G)
Trial: 1329478
Drug: enalapril 5‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril 5‐20 mg once daily
Trial: 29955836
Drug: Adjuvanted recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvanted recombinant zoster vaccine
Trial: 18822978
Drug: Medication (Madopa)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Madopa)
Trial: 12494258
Drug: Seven-valent pneumococcal
RxNorm normalized name: Sevenfact
DrugBank: Coagulation factor VIIa Recombinant Human (DB00036)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seven-valent pneumococcal conjugate vaccine (PCV)
Trial: 10450448
Drug: High-dose ivermectin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ivermectin (up to 1600 micrograms/kg bodyweight)
Trial: 10450448
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of ivermectin (150 micrograms/kg bodyweight)
Trial: 3130257
Drug: BAYo1248 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAYo1248 (40 mg before breakfast)
Trial: 3130257
Drug: BAYm1099 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAYm1099 (100 mg before breakfast and dinner)
Trial: 28450388
Drug: Drug-tolerant assay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-tolerant assay for detecting anti-drug antibodies (ADAs)
Trial: 28450388
Drug: Drug-tolerant assay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-tolerant assay after optimization
Trial: 28450388
Drug: Drug-tolerant assay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-tolerant assay at the end of TAXIT
Trial: 27061185
Drug: Enhanced treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced treatment as usual (control group)
Trial: 23743803
Drug: 10-20 mmol
RxNorm normalized name: ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 10-20 mmol sodium diet and sodium tablets (180 mEq/day)
Trial: 7672157
Drug: Identical placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Identical placebo tablets
Trial: 20426759
Drug: Antiretroviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral treatment interruption for > or =96 weeks
Trial: 20426759
Drug: Maintained antiretroviral
RxNorm normalized name: phenazopyridine
DrugBank: Phenazopyridine (DB01438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maintained antiretroviral therapy
Trial: 15597104
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg m(‐2))
Trial: 15597104
Drug: Docetaxel, irinotecan,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel, irinotecan, and lenogastrim (60 mg m(‐2), 200 mg m(‐2), and 150 microg m(‐2) day(‐1), respectively)
Trial: 12110110
Drug: Magnesium sulphate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate, 1000 mg intravenously
Trial: 12110110
Drug: Placebo (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.9% physiological saline, 10 ml)
Trial: 791605
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg propranolol
Trial: 11773918
Drug: Intermediate-dose efegatran
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate-dose efegatran
Trial: 11773918
Drug: Efegatran sulfate
RxNorm normalized name: SULFATE
DrugBank: Sulfate ion (DB14546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efegatran sulfate (high-dose)
Trial: 29975272
Drug: ACB alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACB alone (15 mL of 0.5% bupivacaine)
Trial: 29975272
Drug: ACB+PAI (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACB+PAI (15 mL of 0.5% bupivacaine + 50 mL of 0.25% bupivacaine with epinephrine)
Trial: 29975272
Drug: PAI alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAI alone (50 mL of 0.25% bupivacaine with epinephrine)
Trial: 24496699
Drug: Olmesartan 20
RxNorm normalized name: olmesartan 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 20 mg once daily for 4 weeks, followed by titration to 40 mg for the next 8 weeks.
Trial: 24496699
Drug: LCZ696 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCZ696 200 mg once daily, titrated to 400 mg, and olmesartan 20 mg, titrated to 40 mg, with possible addition of amlodipine (2.5-5 mg) and hydrochlorothiazide (6.25-25 mg) if BP target not attained.
Trial: 25424990
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg atorvastatin daily
Trial: 19103535
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg atorvastatin every other day
Trial: 10452673
Drug: Famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 20 mg twice a day (H2RA)
Trial: 10452673
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily (PPI)
Trial: 10452673
Drug: Daily drinkers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily drinkers
Trial: 2201825
Drug: Intensive timed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive timed sequential treatment using high dose cytarabine
Trial: 31324358
Drug: High-dose dipyridamole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dipyridamole stress echocardiography (0.84 mg/kg)
Trial: 23486302
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration therapy (WBV) with exercise training
Trial: 14579160
Drug: Transforaminal corticosteroid
RxNorm normalized name: transforming growth factor beta 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transforaminal corticosteroid injection
Trial: 14579160
Drug: Interspinous corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interspinous corticosteroid injection
Trial: 1381218
Drug: granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: granulocyte colony-stimulating factor (G-CSF)
Trial: 23702236
Drug: Speech therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Speech therapy
Trial: 31239114
Drug: Multimodal physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal physical exercise program (1-hour sessions, moderate intensity, twice a week for 12 weeks)
Trial: 29090526
Drug: Capecitabine with
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine with radiation therapy (RT)
Trial: 29090526
Drug: Historical control
RxNorm normalized name: typhus, historical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Historical control (not specified treatment)
Trial: 27636922
Drug: Decimeter wave
RxNorm normalized name: ELECTRODE GEL,H-WAVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decimeter wave therapy and halotherapy in addition to basic drug treatment
Trial: 26852501
Drug: Basic drug
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic drug therapy
Trial: 16258094
Drug: Risk-adapted alternating
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk-adapted alternating short-course multiagent systemic and intrathecal chemotherapy, cranial irradiation if indicated, and conventional maintenance therapy.
Trial: 16258094
Drug: Risk-adapted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk-adapted treatment for group A (early BM relapse).
Trial: 16258094
Drug: Risk-adapted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk-adapted treatment for group B (late BM relapse).
Trial: 16258094
Drug: Risk-adapted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk-adapted treatment for group C (isolated extramedullary relapse).
Trial: 16258094
Drug: Risk-adapted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk-adapted treatment with individual regimens for 24 patients with exceptionally poor prognosis.
Trial: 8062153
Drug: Ipriflavone (IP)
RxNorm normalized name: IPRIFLAVONE
DrugBank: Ipriflavone (DB13618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipriflavone (IP) 600 mg/day
Trial: 28120630
Drug: Ropinirole PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirole PR 16 mg
Trial: 28120630
Drug: Ropinirole PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirole PR 8 mg
Trial: 25641537
Drug: Low-sodium diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium diet (1500 mg/d)
Trial: 25641537
Drug: Moderate-sodium diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-sodium diet (2300 mg/d)